Evrysdi (risdiplam) - Quality defect related to the potential presence of insoluble foreign particles in constituted product

26/06/2026
Medicines for human use Direct healthcare professional communication (DHPC)

Important quality information from Roche Products (Ireland) Limited regarding Evrysdi (risdiplam) - Quality defect related to the potential presence of insoluble foreign particles in constituted product

Documents

Evrysdi – Direct healthcare professional communication (DHPC) – 12 June 2026 (pdf) PDF : 259KB | 29/06/2026